Clinical Trials - July 22, 2015
AZ Drug Tested on Alzheimer’s
An AstraZeneca drug with disappointing results against solid tumors has shown promise in the treatment of Alzheimer’s disease, according to a team at Yale University in the U.S. The drug, AZD0530, attacks one of the key steps in the development of Alzheimer’s–blocking the activation of the enzyme FYN, which interrupts the synaptic connections between brain […]
